Ulf Wiinberg Mi Nk Therapeutics, Inc. (INKT) insider trading activity

Ulf Wiinberg is of MiNK Therapeutics, Inc.. Currently has a direct ownership of 18,971 shares of INKT, which is worth approximately $243,018. The most recent transaction as insider was on Sep 02, 2025, when has been sold 1,011 shares (Common Stock) at a price of $13.86 per share, resulting in proceeds of $14,012. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 19K

5.63% 3M change

84.66% 12M change

Total Value Held $243,018

ULF WIINBERG Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 02 2025	BUY Grant, award, or other acquisition	$14,012 $13.86 p/Share	1,011 Added 5.06%	18,971 Common Stock
Jun 02 2025	BUY Grant, award, or other acquisition	$14,003 $7.17 p/Share	1,953 Added 9.81%	17,960 Common Stock
Mar 03 2025	BUY Grant, award, or other acquisition	$14,002 $8.79 p/Share	1,593 Added 9.05%	16,007 Common Stock
Dec 01 2024	BUY Grant, award, or other acquisition	$14,947 $0.73 p/Share	20,476 Added 12.44%	144,181 Common Stock
Sep 03 2024	BUY Grant, award, or other acquisition	$15,001 $0.82 p/Share	18,295 Added 12.88%	123,705 Common Stock
Jun 03 2024	BUY Grant, award, or other acquisition	$14,926 $0.99 p/Share	15,077 Added 12.51%	105,410 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	$15,000 $0.95 p/Share	15,790 Added 14.88%	90,333 Common Stock
Dec 01 2023	BUY Grant, award, or other acquisition	$15,000 $1.04 p/Share	14,424 Added 16.21%	74,543 Common Stock
Sep 01 2023	BUY Grant, award, or other acquisition	$14,001 $1.46 p/Share	9,590 Added 13.76%	60,119 Common Stock
Jun 01 2023	BUY Grant, award, or other acquisition	$14,000 $1.76 p/Share	7,955 Added 13.56%	50,706 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	$14,000 $2.09 p/Share	6,699 Added 13.55%	42,751 Common Stock
Dec 01 2022	BUY Grant, award, or other acquisition	$14,000 $2.61 p/Share	5,364 Added 12.95%	36,052 Common Stock
Sep 15 2022	BUY Grant, award, or other acquisition	$28,003 $2.62 p/Share	10,688 Added 50.0%	10,688 Common Stock
Jul 19 2022	BUY Open market or private purchase	$23,159 $1.39 p/Share	16,661 Added 5.29%	298,300 Common Stock
Jul 18 2022	BUY Open market or private purchase	$4,441 $1.33 p/Share	3,339 Added 1.17%	281,639 Common Stock

Also insider at

AGEN

AGENUS INC Healthcare

Ulf Wiinberg

Lexington, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INKT shares.

Notify only if

Value

Insider Trading

Get notified when an Mi Nk Therapeutics, Inc. insider buys or sells INKT shares.

Notify only if

Operation

Value

Type

News

Receive news related to MiNK Therapeutics, Inc.

Track Activities on INKT

Account